Introduction
What we are. What we offer.
The program is jointly run by the University of Münster and the Max Planck Institute for Molecular Biomedicine. The CiM Graduate School of the Cells in Motion Interfaculty Centre and the International Max Planck Research School - Molecular Biomedicine were merged to form one graduate program.
The Ph.D. program offers cutting edge science and teaching in Molecular and Cellular Life Sciences with a strong emphasis on Imaging. Although the focus of the program lies on biomedical research, there is also a strong demand for graduates of computer sciences, mathematics, chemistry and physics to work on new ways of image acquisition and analysis as well as on novel labeling methods.
We offer outstanding research in high-profile laboratories as well as excellent scientific and "soft-skill" training aimed to strengthen the PhD students' competences for their future careers. Each year up to 16 PhD students will receive fellowships (tax-free) or work contracts (for more details go to Application). More PhD positions financed by work contracts may be offered depending on availability. There are no tuition fees.
We offer support with visas, accommodation and administrative matters.
You can find more general information on CiM-IMPRS here:
- Article about CiM-IMPRS: Excellent minds from all over the world
- Podcast about CiM-IMPRS: One-track specialists don’t get far
- Podcast series "Scientific life"
For more information on our projects and training program visit the respective pages:
CiM-IMPRS is open for highly qualified and motivated students of any nationality. We also encourage students who have obtained a Master's degree at Münster University to apply for a CiM-IMPRS fellowship.
We are looking forward to your application for a PhD fellowship in Münster, "the world's most liveable city" (LivCom Award 2004).
CiM and IMPRS-MBM are supported by (alphabetical listed): Deutsche Forschungsgemeinschaft, Max Planck Institute for Molecular Biomedicine, Max Planck Society, University of Münster.